SCHEMBL8943053

SCHEMBL8943053

O=c1[nH]c2ccccc2n1CCCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 5/20 0.86
ADRA1A P35348 2/20 0.86
DRD3 P35462 2/20 0.86
ABCB11 O95342 1/20 0.86
ADRA2A P08913 1/20 0.86
ADORA3 P0DMS8 1/20 0.86
CHRM1 P11229 1/20 0.86
DRD1 P21728 1/20 0.86
TBXA2R P21731 1/20 0.86
SLC6A4 P31645 1/20 0.86
OPRM1 P35372 1/20 0.86
KCNH2 Q12809 1/20 0.86
HTR7 P34969 13/20 0.74
LMNA P02545 2/20 0.61
TP53 P04637 2/20 0.61
MAPT P10636 2/20 0.61
SIGMAR1 Q99720 1/20 0.61
GAA P10253 1/20 0.60
MAPK1 P28482 1/20 0.60
HTT P42858 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8121534 0.99 HTR1A (0.88) HTR1AADRA1ADRD3ABCB11ADRA2A
SCHEMBL8121051 0.97 HTR1A (0.88) HTR1AADRA1ADRD3ABCB11ADRA2A
Flibanserin SCHEMBL29399513 0.93 HTR1A (1.00) HTR1AADRA1ADRD3ABCB11ADRA2A
Flibanserin SCHEMBL247579 0.93 HTR1A (1.00) HTR1AADRA1ADRD3ABCB11ADRA2A
Flibanserin SCHEMBL30249132 0.93 HTR1A (1.00) HTR1AADRA1ADRD3ABCB11ADRA2A
Flibanserin SCHEMBL19743151 0.92 HTR1A (0.98) HTR1AADRA1ADRD3ABCB11ADRA2A
Flibanserin SCHEMBL563586 0.92 HTR1A (0.98) HTR1AADRA1ADRD3ABCB11ADRA2A
Flibanserin SCHEMBL2526226 0.92 HTR1A (0.98) HTR1AADRA1ADRD3ABCB11ADRA2A
Flibanserin SCHEMBL19743166 0.92 HTR1A (0.98) HTR1AADRA1ADRD3ABCB11ADRA2A
SCHEMBL8123196 0.89 HTR1A (0.92) HTR1AADRA1ADRD3ABCB11ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5576318-A FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BOEHRINGER INGELHEIM ITALIA S.P.A. (IT) 1996-11-19 US disclosed